IL-2-regulated persistent human herpesvirus-6B infection facilitates growth of adult T cell leukemia cells

Journal of Medical and Dental Sciences

Volumn 52, Issue 2, 2005, Pages 135-141

  Ojima, Tomoko ^a   Abe, Kenji ^a   Ohyashiki, Junko H ^a   Shirakata, Masaki ^a   Yamamoto, Kohtaro ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

ATL; HHV 6; IL 2

Indexed keywords

ANTIVIRUS AGENT; GANCICLOVIR; INTERLEUKIN 2; RECOMBINANT PROTEIN; VIRUS DNA; VIRUS ENVELOPE PROTEIN;

ADULT; ARTICLE; CELL PROLIFERATION; DRUG EFFECT; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; HUMAN; HUMAN HERPESVIRUS 6; PATHOGENICITY; T CELL LEUKEMIA; T LYMPHOCYTE; TUMOR CELL LINE; VIROLOGY; VIRUS REPLICATION;

ADULT; ANTIVIRAL AGENTS; CELL LINE, TUMOR; CELL PROLIFERATION; DNA, VIRAL; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; GANCICLOVIR; HERPESVIRUS 6, HUMAN; HUMANS; INTERLEUKIN-2; LEUKEMIA, T-CELL; RECOMBINANT PROTEINS; T-LYMPHOCYTES; VIRAL ENVELOPE PROTEINS; VIRUS REPLICATION;

EID: 26944485911     PISSN: 13428810     EISSN: 13428810     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Salahuddin SZ, Ablashi DV, Markham PD, et al. Isolation of a new virus, HBLV, in patients with lymphoproliferative disorders. Science 1986;234:596-601.
2. Ablashi DV, Balachandran N, Josephs SF, et al. Genomic polymorphism, growth properties, and immunogical variations in human herpesvirus-6 isolates. Virology 1991;184:545-552.
3. Aubin JT, Collandre H, Candotti D, et al. Several groups among human herpesvurus 6 strains can be distinguished by Southern blotting and polymerase chain reaction. J Clin Microbiol 1991;29:367-372.
4. Chandran B, Tirawatnapong S, Pfeiffer B, et al. Antigenic relationships among human herpesvirus-6 isolates. J Med Virol 1992;37:247-245.
5. Hall CB, Caserta MT, Schnabel KC, et al. Persistence of human herpesvirus 6 according to site and variant: possible greater neurotropism of variant A. Clin Infect Dis 1998;26,132-137.
6. Yamanishi K, Okuno T, Shiraki K, et al. Identification of human herpesvirus-6 as a causal agent for exanthema subitum. Lancet 1988;1:1065-1067.
7. Saxinger C, Polesky H, Eby N, et al. Antibody reactivity with HBLV (HHV-6) in U.S. populations. J Virol Methods 1988;21:199-208.
8. Yoshikawa T, Nakashima T, Suga S, et al. Human herpesvirus-6 DNA in cerebrospinal fluid of a child with exanthem subitum and meningoencephalitis. Pediatrics 1992;89:888-890.
9. Lusso P, Markham PD, Tschachler E, et al. In vitro cellular tropism of human B-lymphotropic virus (human herpesvirus 6). J Exp Med 1988;167:1659-1670.
10. Takahashi K, Sonoda S, Higashi K, et al. Predominant CD4 T-lymphocyte tropism of human herpesvirus-6 infection and the course of human immunodeficiency virus infection. J Infect Dis 1989;161:3161-3163.
11. Kondo K, Kondo T, Okuno T, et al. Latent human herpesvirus 6 infection of human monocytes/macrophages. J Gen Virol 1991;72:1401-1408.
12. Kondo K, Shimada K, Sashihara J, et al. Identification of human herpesvirus 6 latency-associated transcripts. J Virol 2002;76:4145-4151.
13. Ensoli B, Lusso P, Schachter F, et al. Human herpes virus-6 increases HIV-1 expression in co-infected T cells via nuclear factors binding to the HIV-1 enhancer. EMBO J 1989;8:3019-3027.
14. Lusso P, Ensoli B, Markham PD, et al. Productive dual infection of human CD4+ T-lymphocytes by HIV-1 and HHV-6. Nature 1989;337:370-373.
15. Horvat RT, Wood C, Balachandran N. Transactivation of human immunodeficiency virus promoter by human herpesvirus 6. J Virol 1989;63:326-335.
16. Sieczkowski L, Chandran B, Wood C. The human immunodeficiency virus tat gene enhances replication of human herpesvirus-6. Virology 1995;211:544-553.
17. Carrigan DR, Knox KK, Tapper MA. Suppression of human immunodeficiency virus type 1 replication by human herpevirus-6. J Infect Dis 1990;162:844-851.
18. Levy JA, Landay A, Lennette ET. Human herpesvirus 6 inhibits human immunodeficiency virus type 1 replication in cell culture. J Clin Microbiol 1990;28:2362-2364.
19. Asada H, Klaus-Kovtun V, Goldin H, et al. Human herpesvirus 6 infects dendritic cells and suppresses human immunodeficiency virus type 1 replication in coinfected cultures. J Virol 1999;73:4019-4028.
20. Cocchi F, De Vico AL, Garzino-Demo A, et al. Identification of RANTES, RANTES, MIP1α, and MIP1β as the major HIV-suppressive factors produced by CD8+ T cells. Science 1995;270:1811-1815.
21. Grivel J-C, Ito Y, Faga G, et al. Suppression of CCR5- but not CXCR4-tropic HIV-1 in lymphoid tissue by human herpesvirus 6. Nature Med 2001;7:1232-1235.
22. Lusso P, Maria AD, Malnati M, et al. Induction of CD4 and susceptibility to HIV-1 infection in CD8+ human T lymphocytes by human herpesvirus 6. Nature 1991;349:533-535.
23. Lusso P, Malnati M, Garzino-Demo A, et al. Infection of natural killer cells by human herpesvirus 6. Nature 1993;362:458-462.
24. Lusso P, Garzino-Demo A, Crowley RW, et al. Infection of γ/δ T lymphocytes by human herpesvirus 6: transcriptional induction of CD4 and susceptibility to HIV infection. J Exp Med 1995;181:1303-1310.
25. Mayne M, Cheadle C, Solden SS, et al. Gene expression profile of herpesvirus-infected T cells obtained using immunomicroarrays: induction of proinflammatory mechanisms. J Virol 2001;75:11641-11650.
26. Yasukawa M, Hasegawa A, Sakai I, et al. Down-regulation of CXCR4 by human herpesvirus 6 (HHV-6) and HHV-7. J Immunol 1999;162:5417-5422.
27. Isegawa Y, Ping Z, Nakano K, et al. Human herpesvirus 6 open reading frame U12 encodes a functional β chemokine receptor. J Virol 1998;72: 6104-6112.
28. Milne RS, Mattick C, Nicholson L, et al. RANTES binding and down-regulation by a novel human herpesvirus-6 beta chemokine receptor. J Immunol 2000;164:2396-404.
29. Zou P, Isegawa Y, Nakano K, et al. Human herpesvirus 6 open reading frame U83 encodes a functional chemokine. J Virol 1999;73:5926-5933.
30. Uchiyama T. Human T cell leukemia virus type I (HTLV-I) and human diseases. Ann Rev Immunol 1997;15:15-37.
31. Zhou CF, Abe K, Wang P, et al. Susceptibility of the adult T cell leukemia (ATL) cell lines to HHV-6B. Leukemia 1998;12:1001.
32. Zhou CF, Abe K, Wang P, et al. Efficient propagation of human herpesvirus 6B in a T-cell line derived from a patient with adult T-cell leukemia/lymphoma. Microbiol Immunol 1999;43:425-436.
33. Kikuta H, Lu H, Matsumoto S, et al. Polymorphism of human herpesvirus-6 DNA from five Japanese patients with exanthema subitum. J Infect Dis 1989;160:550-551.
34. Roffman E, Frenkel N. Interlrukin-2 inhibits the replication of human herpesvirus-6 in mature thymocytes. Virology 1990;175:591-594.
35. Agut H, Huraux JM, Collandre H, et al. Susceptibility of human herpesvirus 6 to acyclovir and ganciclovir. Lancet 1989;2:626.
36. Ansari A, Emery VC. The U69 gene of human herpesvirus 6 encodes a protein kinase which can confer ganciclovir sensitivity to Baculoviruses. J Virol 1999;73:3284-3291.
37. Burns WH, Sandford G.R. Susceptibility of human herpesvirus 6 to antivirals in vitro. J Infect Dis 1990;162:634-637.
38. Jault FM, Jault J-M, Ruchti, F, et al. Cytomegalovirus infection induces high levels of cyclins, phosphorylated RB, and p53, leading to cell cycle arrest. J Virol 1995;69:6697-6704.
39. Lu M, Shenk T. Human cytomegalovirus infection inhibits cell cycle progression at multiple points, including the transition from G1 to S. J Virol 1996;70:8850-8857.
40. De Bolle L, Hatse S, Verbeken E, et al. Human herpesvirus 6 infection arrests cord blood mononuclear cells in G2 phase of the cell cycle. FEBS Letters 2004;560:25-29.
41. Salonen MJH, Siimes MA, Salonen E-M, et al. Antibody status to HHV-6 in children with leukemia. Leukemia 2002;16:716-719.